2023 international evidence-based guideline pcos glp-1 receptor agonist A perspective on precision therapeutics in polycystic ovary syndrome: integrating multi-omics, AI-driven stratification, and emerging biologics GLP-1 Receptor Agonists, Fertility Restoration,

Liver Disease Cancer What is the quickest, most effective way to correct a Vitamin B12 deficiency

GLP-1 RAs and other breakthroughs, such as dual and triple agonist drugs, might be just what the 21st century lazy human body needs to circumvent the deleterious effects of lifestyle disorders

Retatrutide and tesamorelin are both peptide-based compounds that have attracted significant interest in metabolic medicine, though they differ considerably in their origins, mechanisms, and clinical applications

CJC 1295, on the other hand, is a modified version of GHRH that enhances growth hormone secretion and promotes muscle growth and fat loss

Mojca Jensterle, from the University Medical Center Ljubljana, explains: "The combined action of both pharmacotherapies, GLP-1 and metformin, may be more effective than the individual action of each drug for the treatment of the metabolic and reproductive disturbances linked to PCOS and may even improve metabolic outcomes in women who previously exhibited deficient responses to metformin." Mojca Jensterle, Department of Endocrinology, University Medical Center Ljubljana Interestingly, metformin has the ability to enhance the bodys natural GLP-1 levels, which might allow for lower doses of GLP-1 receptor agonists without sacrificing results

PMID: 34045438 Signal Transduct Target Ther Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis